Back to Market Feed

Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.3161 per EA under NDC 51672422201. Its NADAC has been published 309 times since Sep 23, 2020.

FDA first approved this application on Jul 1, 2020. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE

butalbital, acetaminophen, and caffeine
$0.3161per EA
DEA Schedule CIII

Strength

300; 50; 40 mg/1; mg/1; mg/1

NDC

51672422201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213046

FDA Approved

7/1/2020

TE Code

AA

On Market Since

7/1/2020

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 309 times since Sep 23, 2020, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3161 per EA
All-time high$0.9893 (Dec 16, 2020)
All-time low$0.3110 (Apr 22, 2026)
52-week high$0.4517
52-week low$0.3110
Median price$0.5732
Average price$0.5689
Largest weekly change+34.5% (Jun 19, 2024)
Weeks tracked309
Tracking sinceSep 23, 2020

Price History

1W

-1.2%

1M

-1.2%

3M

-4.6%

6M

-5.0%

1Y

-30.0%

3Y

-42.3%

5Y

-52.3%

All

-61.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the butalbital, acetaminophen, and caffeine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0638
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0638
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0649
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0649
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0649
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0649
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0649
per EA

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.3161 per EA (NDC 51672422201), effective Aug 19, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 61.7%. It has been tracked across 309 weekly CMS publications since Sep 23, 2020.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

Since Sep 23, 2020, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $0.9893 (Dec 16, 2020), with a median of $0.5732 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 51672422201) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.